Racial disparities in lipid control in patients with diabetes

American Journal of Managed Care

Volumn 18, Issue 6, 2012, Pages 303-311

  Saffar, Darcy ^a,b   Williams, L Keoki ^a   Lafata, Jennifer Elston ^a   Divine, George ^a   Pladevall, Manel ^a,c  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c RTI HEALTH SOLUTIONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AFRICAN AMERICAN; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; DIABETES MELLITUS; EUROPEAN AMERICAN; FEMALE; GOAL ATTAINMENT; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RACE DIFFERENCE;

AFRICAN AMERICANS; CHOLESTEROL, LDL; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; HEALTH STATUS DISPARITIES; HUMANS; HYPERLIPIDEMIAS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; INSURANCE CLAIM REVIEW; LIPIDS; MEDICATION ADHERENCE; MULTIVARIATE ANALYSIS; ODDS RATIO; UNITED STATES;

EID: 84864396781     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Echouffo-Tcheugui JB, Sargeant LA, Prevost AT, et al. How much might cardiovascular disease risk be reduced by intensive therapy in people with screen-detected diabetes? Diab Med. 2008;25(12):1433-1439.
2. Gerstein HC, Swedberg M, Carlsson J, et al. The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Arch Intern Med. 2008;168(15):1699-1704.
3. Keevil JG, Cullen MW, Gangnon R, McBride PE, Stein JH. Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the US for the diagnosis and treatment of dyslipidemia. Circulation. 2007;115(11):1363- 1370.
4. Wierzbicki AS. Interpreting clinical trials of diabetic dyslipdaemia: new insights. Diabetes Obes Metab. 2009;11(3):261-270.
5. Clark LT, Maki KC, Galant R, Maran DJ, Pearson TA, Davidson MH. Ethnic differences in achievement of cholesterol treatment goals. J Gen Intern Med. 2006;21(4):320-326.
6. Mann D, Reynolds K, Smith D, Muntner P. Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program Guidelines. Ann Pharmacother. 2008;42(9):1208-1215.
7. Mensah GA, Mokdad AH, Ford ES, Greenlund KJ, Croft JB. State of disparities in cardiovascular health in the United States. Circulation. 2005:111(10):1233-1241. (Pubitemid 40389086)
8. Yood MU, McCarthy BD, Kempf J, et al. Racial differences in target low-density lipoprotein goal among individuals treated with prescription statin therapy. Am Heart J. 2006;152(4):777-784. (Pubitemid 44396880)
9. Goff Jr DC, Bertoni AG, Kramer H, et al. Dyslipidemia prevalence, treatment, and control in the multi-ethnic study of atherosclerosis (MESA). Circulation. 2006;113(5):647-656.
10. Hendrix KH, Richle JE, Egan BM. Ethnic, gender, and age-related differences in treatment and control of dyslipidemia in hypertensive patients. Ethn Dis. 2005;15(1):11-16. (Pubitemid 40320433)
11. Massing MW, Foley KA, Carter-Edwards L, et al. Disparities in lipid management for African Americans and Caucasians with coronary artery disease: a national cross-sectional study. BMC Cardiovasc Disord. 2004;4:15-20.
12. Safford M, Eaton L, Hawley G, et al. Disparities in use of lipid-lowering medications among people with type 2 diabetes mellitus. Arch Intern Med. 2003;163(8):922-928. (Pubitemid 36522738)
13. Sonel AF, Good CB, Mulgund J, et al. Racial variations in treatment and outcomes of black and white patients with high-risk non-ST-elevation acute coronary syndromes. Circulation. 2005;111(10):1225-1232.
14. Trivedi AN, Zaslavsky AM, Schneider EC, Ayanian JZ. Trends in the quality of care and racial disparities in Medicare managed care. N Engl J Med. 2005;353(7):692-700. (Pubitemid 41175677)
15. Heisler M, Faul JD, Hayward, RA, Langa KM, Blaum C, Weir D. Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study. Arch Intern Med. 2007;167(17):1853-1860. (Pubitemid 47481480)
16. Yancy CW, Benjamin EJ, Fabunmi RP, Bonow RO. Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: executive summary. Circulation. 2005;111(10):1339-1349. (Pubitemid 40389102)
17. Adams AS, Trinacty CM, Zhang F, et al. Medication adherence and racial differences in A1C control. Diabetes Care. 2008;31(5):916-921.
18. Brown AF, Gregg EW, Stevens MR, et al. Race, ethnicity, socioeconomic position, and quality of care for adults with diabetes enrolled in managed care. Diabetes Care. 2005;28(12):2864-2870.
19. Mark TL, Axelsen KJ, Mucha L, Sadkova Y. Racial differences in switching, augmentation, and titration of lipid-lowering agents by Medicare/Medicaid dual-eligible patients. Am J Manag Care. 2007;13(suppl 3):S72-S79.
20. Mensah GA. Eliminating disparities in cardiovascular health: six strategic imperatives and a framework for action. Circulation. 2005;111(10):1332-1336. (Pubitemid 40389100)
21. Selby JV, Swain BE, Gerzoff RB, et al. Understanding the gap between good processes of diabetes care and poor intermediate outcomes. Med Care. 2007;45(12):1144-1153.
22. Freeman HP, Payne R. Racial injustice in health care. N Engl J Med. 2000;342(14):1045-1047. (Pubitemid 30180655)
23. Mahotier T, Ocepek-Welikson K, Daley MB, Byssainthe JP. A program to reduce the disparity in the rate of biennial lipid profiles between African American and white Medicare beneficiaries with diabetes mellitus in New York City. J Community Health. 2006;31(4):263-288. (Pubitemid 43988355)
24. Heisler M, Smith DM, Hayword RA, et al. Racial disparities in diabetes care processes, outcomes, and treatment intensity. Med Care. 2003;41(11)1221-1232.
25. Duru OK, Gerzoff RB, Selby JV, et al. Identifying risk factors for racial disparities in diabetes outcomes. Med Care. 2009;47(6):700-706.
26. Grant R, Adams AS, Trinacty CM, et al. Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care. 2007;30(4):807-812. (Pubitemid 46556571)
27. Huang ES, Brown SE, Thakur N, et al. Racial/ethnic differences in concerns about current and future medications among patients with type 2 diabetes. Diabetes Care. 2009;32(2):311-316.
28. Schetman JM, Nadkami MM, Voss JD. The association between diabetes metabolic syndrome and drug adherence in an indigent population. Diabetes Care. 2002;25:1015-1021. (Pubitemid 41110487)
29. National Committee for Quality Assurance, Health Plan Employer Data and Information Set (HEDIS 3.0), developed under the auspices of the Committee on Performance Management. January 1997.
30. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
31. Selby JV. Linking automated databases for research in managed care. Ann Intern Med. 1997;127(8, pt 2):719-724. (Pubitemid 27446554)
32. Lafata JE, Martin S, Morlock R, Divine G, Xi H. Provider type and the receipt of general and diabetes related preventive health services among patients with diabetes. Med Care. 2001;39(5):491-499. (Pubitemid 33702451)
33. Sikka R, Xia F, Aubert RE. Estimating medication persistency using medical claims data. Am J Manag Care. 2005;11(7):449-457. (Pubitemid 41022729)
34. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50(1)105-116. (Pubitemid 27089212)
35. Williams LK, Pladevall M, Peterson EL, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol. 2004;114(6):1288-1293. (Pubitemid 39575880)
36. Nau DP, Steinke DT, Williams LK, et al. Adherence analysis using visual analog scale versus claims-based estimation. Ann Pharmacother. 2007;41(11):1792-1797. (Pubitemid 350044340)
37. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40(9):794-811.
38. Williams LK, Peterson EL, Wells K, et al. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroidsnonadherence [published online ahead of print October 20, 2011]. J Allergy Clin Immunol.
39. Pladevall M, Williams LK, Potts LA, Divine G, Xi H, Lafata JE. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care. 2004;27(12):2800-2805. (Pubitemid 39565040)
40. Parris ES, Lawrence DB, Mohn LA, Long LB. Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia. Diabetes Care. 2005;28(3):595-599. (Pubitemid 40315319)
41. Vine MF, Degnan D, Hanchette C. Geographic information systems: their use in environmental epidemiologic research. Environ Health Perspect. 1997;105(6):598-605. (Pubitemid 27405808)
42. Rochon J. Application of GEE procedures for sample size calculations in repeated measures experiments. Stat Med. 1998;17:1643-1658. (Pubitemid 28367844)
43. Schimittdiel JA, Uratsu CS, Karter AJ, et al. Why don't patients achieve recommended risk factor targets? poor adherence versus lack of treatment intensification. J Gen Intern Med. 2008;23(5):588-594.
44. Traylor AH, Subramanian U, Uratsu CS, et al. Patient race/ethnicity and patient-physician race/ethnicity concordance in the management of cardiovascular disease risk factors for patients with diabetes. Diabetes Care. 2010;33(3):520-525.
45. van Ryn M. Research on the provider contribution to race/ethnicity disparities in medical care. Med Care. 2002;40(1 suppl):140-151.
46. Lafata JE, Dobie EA, Divine GW, Ulcickas Yood ME, McCarthy BD. Sustained hyperglycemia among patients with diabetes. Diabetes Care. 2009;32(8):1447-1452.
47. Kaplan RC, Bhalodkar NC, Brown EJ Jr, White J, Brown DL. Race, ethnicity, and sociocultural characteristics predict noncompliance with lipid-lowering medications. Prev Med. 2004;39(6):1249-1255. (Pubitemid 39468643)
48. Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14(1):1-24.
49. Ciechanowski PS, Katon WJ, Russo JE, Hirsch IB. The relationship between depressive symptoms to symptom reporting, self-care, and glucose control in diabetes. Gen Hosp Psychiatry. 2003;25(4):246-252. (Pubitemid 36802269)
50. Krein SL, Heisler M, Piette JD, et al. The effect of chronic pain on diabetes patients'self-management. Diabetes Care. 2005;28(1):65-70. (Pubitemid 40095784)
51. Williams LK, Joseph CL, Peterson EL, et al. Patients with asthma who do not fill their inhaled corticosteroids: a study of primary nonadherence. J Allergy Clin Immunol. 2007;120(5):1153-1159. (Pubitemid 350029905)
52. Stratton MA, Jordan AH, Harrison DL, Jacobs VW, Scaggs VJ. Disparities in the prevalence of medication therapy for hyperlipidemia in the elderly. Consult Pharm. 2007;22(10):847-854. (Pubitemid 350060114)
53. Rathore SS, Ketcham JD, Alexander GC, Epstein AJ. Influence of patient race on physician prescribing decisions: a randomized on-line experiment. J Gen Intern Med. 2009;24(11):1183-1191.
54. Piette JD, Wagner TH, Potter MB, Schillinger D. Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Med Care. 2004;42(2):102-109.
55. Wagner TH, Heisler M, Piette JD. Prescription drug co-payments and cost-related medication underuse. Health Econ Policy Law. 2008;3(pt 1):51-67. (Pubitemid 351283145)
56. Tseng CW, Tierney EF, Gerzoff RB, et al. Race/ethnicity and economic differences in cost-related medication underuse among insured adults with diabetes: the Translating Research into Action for Diabetes Study. Diabetes Care. 2008;31(2):261-266. (Pubitemid 351213332)
57. Trinacty CM, Adams AS, Soumerai SB, et al. Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study. BMC Health Serv Res. 2009;9:24